«The number of people who live with diabetes is on the rise. The World Health Organisation (WHO) estimates that one in eleven people are affected by the disease. This makes the auto-injector market one of the fastest growing subsets of the pharmaceutical industry. Moreover, with the rise of biologic and sustained release drugs, the market will see an even greater demand for auto-injectors in the future.»

«Strict regulations by the Food and Drug Administration (FDA) for these class II devices mean that testing to ISO 11608-5 is a critical step for manufacturers in guaranteeing the quality and safety of its products. Whether testing is managed in-house or handled by a contract testing laboratory, for one or for many different product designs, these companies are turning to testing platforms that are both versatile and comprehensive. Testing must support manufacturing protocols and industry regulations, while maintaining absolute accuracy and reducing time to market.»

Article written by ALAN THOMAS



Med Tech News